Health Catalyst (HCAT) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$292.2M

Revenue (quarter)

$70.5M

Revenue growth (year over year)

−12.68%

Gross profit (trailing twelve months)

$147.5M

Gross margin

50.48%

Net income (trailing twelve months)

−$264.8M

Net income (quarter)

−$40.5M

Net income growth (year over year)

+1.08%

Net margin

−90.61%

Return on equity

−118.12%

EPS (trailing twelve months)

−$3.68

Book value per share

$1.35

P/E (trailing twelve months)

—

Price to book

1.30

Debt to assets

71.88%

Payout ratio

—

Dividend yield

—

Company profile

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

• Is Health Catalyst (HCAT) profitable?

  No. Health Catalyst reported a net loss of $264.8M over the trailing twelve months.

• How much revenue does Health Catalyst (HCAT) make?

  Health Catalyst generated $292.2M in revenue over the trailing twelve months, down 12.68% year over year.

• How do I buy stock in Health Catalyst (HCAT)?

  HCAT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.